Tus kws kho mob
P63-17 New Drug-Related PA with Quantity Limit Criteria: Otezla (apremilast)
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 06, 2017
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2791 - 2800 ntawm 4179
Tus kws kho mob
P63-16 Drug Related Prior Authorization Criteria Changes for Ampyra, H.P. Acthar Gel, Transmucosal Fentanyl, Growth Hormone, and Oral Pulmonary Arterial Hypertension Agents
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 20, 2016
Tus kws kho mob
P31-17 New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Thrombopoietin Receptor Agents
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 05, 2017
Tus kws kho mob
P57-17 Addition of Drugs to the Self-Administered Oncology Prior Authorization with Quantity Limit Program
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 24, 2017
Tus kws kho mob
P39-17 Concurrent Review for Inpatient Hospital Services at Select Facilities
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 11, 2017
Tus kws kho mob
P62-16 EY Modifier for Platinum Blue Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 13, 2016
Tus kws kho mob
P32-16 New Drug-Related Prior Authorization Criteria with Quantity Limit for Kuvan
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 27, 2016
Tus kws kho mob
P42-16 Change in Medical Policy and Commercial Benefit Coverage of Cologuard Colorectal Cancer Screening Test
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 08, 2016
Tus kws kho mob
P1-17 Prior Authorization Requirement for Gender Dysphoria
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 18, 2017
Tus kws kho mob
P44-16 Addition of a Drug (Viekira XR) to the Hepatitis C Second Generation Prior Authorization with Quantity Limit Program
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 01, 2016